Dr. Connolly is an Assistant Professor of Oncology with an interest in breast cancer. Her principal research activities consist of designing and conducting clinical trials that test investigational new drugs in the treatment of breast cancer. Dr. Connollys current focus relates to the investigation of novel agents in both the neoadjuvant and metastatic settings. She has specific expertise in the use of epigenetic modifiers in breast cancer patients. In addition, she is interested in developing both tissue and imaging-based biomarkers of response to breast cancer therapies. As a clinical investigator with a focus on translational drug development, her goal is to improve outcomes for patients with breast cancer in a research environment.

Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 2007 Mar 1; 109(5):832-9. (PMID 17243168)

Connolly R, Visvanathan K. Research Highlights. Pharmacogenomics Dec 2008; 9 (12): 1797-99. (PMID 19072638)

Connolly R, Wolff AC. Pregnancy and fertility with breast cancer: what are the options? Oncology (Williston Park). 2009 May; 23(6):478, 481.(PMID 19544687)

Connolly R, McCaffrey JA. High-Dose Chemotherapy Plus Stem Cell Transplantation in Advanced Germ Cell Cancer: A Review. European Urology July 2009. 56(1): 57-64. (PMID 19303697)

Connolly R, Stearns V. The Role of Pharmacogenetics in Selection of Breast Cancer Treatment. Current Breast Cancer Reports 2009, 1:190-197

Connolly R, Stearns V. A Multidisciplinary Approach to Neoadjuvant Therapy for Primary Operable Breast Cancer: Challenges and Opportunities. Oncology (Williston Park) February 2010; 24(2):135-143.

Connolly RM, Wolff AC. International Disparities in Breast Cancer Outcomes: The Time to Close the Gap is Now. Oncology (Williston Park) 2010. Nov 30; 24(13):1236-7. (PMID 21192556)

Connolly R, Stearns V. Pharmacogenetics of Aromatase Inhibitors: Present Understanding and Looking to the Future. Current Breast Cancer Reports 2010; 2:138145.

Connolly RM, Rudek MA, Garrett-Mayer E, Jeter SC, Donehower MG, Wright LA, Zhao M, Fetting JH, Emens LA, Stearns V, Davidson NE, Baker SD, Wolff AC. Docetaxel Metabolism is not Altered by Imatinib: Findings from an Early Phase Study in Metastatic Breast Cancer. Breast Cancer Research and Treatment 2011, Feb 25 [Epub ahead of print] (PMID 21350820)
Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta-Blockers and Breast Cancer Mortality: A Population-Based Study. Journal of Clinical Oncology 2011 May 31 [Epub ahead of print] (PMID 21632503)

Connolly RM, Carducci M, Antanorakis E. Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence. Asian Journal of Andrology 2012 (in press)